RPL38 (Ribosomal Protein L38) encodes a ribosomal protein component of the 60S large ribosomal subunit. RPL38 is notable for its critical role in embryonic development, particularly in Hox gene regulation and neural crest cell formation, and for its association with Diamond-Blackfan anemia (DBA) and Treacher Collins syndrome[@gazda2024][@diamondblackfan2020]. Unlike many other ribosomal proteins, RPL38 has specialized functions in translational control of specific mRNAs involved in development, making it uniquely important for understanding both developmental disorders and disease mechanisms[@barna2011][@entrena2019].
| Full Name | Ribosomal Protein L38 |
|---|
| Gene Symbol | RPL38 |
|---|
| Chromosomal Location | 8q24.3 |
|---|
| NCBI Gene ID | 6169 |
|---|
| OMIM | 604365 |
|---|
| Ensembl ID | ENSG00000120314 |
|---|
| UniProt ID | Q70EL2 |
|---|
| Protein Length | 71 amino acids |
|---|
| Protein Molecular Weight | ~8 kDa |
|---|
| Associated Diseases | [Diamond-Blackfan Anemia](/diseases/diamond-blackfan-anemia), [Treacher Collins Syndrome](/diseases/treacher-collins-syndrome), [Ribosomopathies](/diseases/ribosomopathies) |
|---|
RPL38 is a component of the 60S large ribosomal subunit, contributing to the structural integrity and functional capacity of the ribosome[@warner2009]. As part of the translation machinery, RPL38 participates in:
- Protein synthesis: Contributes to peptide bond formation at the peptidyl transferase center
- Ribosome assembly: Essential for proper 60S subunit biogenesis
- rRNA interaction: Interacts with 28S rRNA to stabilize the large subunit
- Translation termination: Participates in the release factor binding site
One of the most distinctive functions of RPL38 is its role in regulating Hox gene translation during embryonic development[@barna2011][@entrena2019]:
The Mechanism:
- Hox genes encode transcription factors that determine body plan and segmental identity
- RPL38 is specifically required for efficient translation of specific Hox mRNAs
- Without RPL38, Hox protein synthesis is impaired, leading to developmental defects
- This represents a specific translational control mechanism rather than general translation impairment
Developmental Importance:
- RPL38 is essential for proper vertebrate tissue patterning
- Mutations in RPL38 cause characteristic birth defects due to Hox dysregulation
- This function explains the severe phenotype of RPL38 mutations compared to other ribosomal proteins
| Protein |
60S Assembly |
p53 Pathway |
Hox Regulation |
Developmental Role |
| RPL5 |
Yes |
Strong |
Limited |
Moderate |
| RPL11 |
Yes |
Strong |
Limited |
Moderate |
| RPL38 |
Yes |
Limited |
Strong (unique) |
Critical |
| RPL23 |
Yes |
Strong |
Limited |
Moderate |
RPL38 mutations cause Diamond-Blackfan anemia, a pure red cell aplasia characterized by failure of red blood cell production[@gazda2024][@diamondblackfan2020]. RPL38 mutations represent a smaller percentage of DBA cases but cause distinctive clinical features:
Clinical Phenotype:
- Macrocytic anemia presenting in infancy or early childhood
- Growth retardation
- Variable skeletal anomalies
- Distinctive facial features in some cases
- Increased risk of solid tumors
Molecular Mechanism:
- RPL38 haploinsufficiency leads to impaired 60S biogenesis
- Ribosomal stress activates p53 through MDM2 inhibition
- Erythroid precursors are particularly sensitive to ribosomal stress
- p53-mediated apoptosis reduces erythroid progenitor pool
RPL38 is involved in Treacher Collins syndrome, a craniofacial disorder caused by mutations in ribosome biogenesis genes[@entrena2019]. This highlights RPL38's critical role in:
- Neural crest cell development: RPL38 is essential for proper neural crest formation
- Craniofacial morphogenesis: Mutations cause characteristic facial abnormalities
- Embryonic development: The specific requirement for RPL38 in Hox regulation explains the tissue-specific phenotype
RPL38 functions as a tumor suppressor through its ribosomal and potentially p53-related functions[@chen2022]:
- Ribosomal protein mutations are found in various cancers
- RPL38 deficiency may allow unchecked cell proliferation
- Altered RPL38 expression observed in multiple tumor types
- The ribosomal stress response provides a fail-safe against oncogenic transformation
While not directly implicated in neurodegenerative diseases, RPL38 biology informs our understanding of neurodegeneration[@zhou2022][@ding2005]:
Ribosomal Stress and Neuronal Death:
- Chronic ribosomal stress can lead to p53 activation in neurons
- p53 activation can trigger neuronal apoptosis
- Ribosomal dysfunction is observed in Alzheimer's, Parkinson's, and ALS
Translational Dysregulation in Neurodegeneration:
- Global translation deficits are observed in AD and PD brains
- Ribosomal proteins including RPL38 may contribute to impaired protein synthesis in neurons
- Specific translational control mechanisms may be affected
Protein Homeostasis:
- Impaired ribosome function disrupts proteostasis
- Protein aggregation is a hallmark of neurodegenerative diseases
- RPL38-mediated stress response may be relevant to proteostatic failure
RPL38 has a distinctive expression pattern compared to other ribosomal proteins:
Tissue Distribution:
- High expression: Embryonic tissues, particularly during neural tube development
- Moderate expression: Adult brain, especially in neuronal populations
- Ubiquitous: Low to moderate expression across most tissues
Developmental Expression:
- RPL38 expression is highest during embryonic development
- Critical for proper segmentation and tissue patterning
- The specific requirement during development explains the severe phenotype of mutations
Cellular Localization:
- Primarily cytoplasmic in ribosomal complexes
- May have nuclear functions related to ribosome biogenesis
RPL38 expression in the nervous system:
- Expressed in neurons and glial cells
- Important for neuronal protein synthesis
- Required for proper brain development
- May be affected in neurodegenerative conditions
In blood-forming tissues:
- Expressed in bone marrow progenitor cells
- Critical for erythroid differentiation
- Sensitive to RPL38 levels explains bone marrow failure in DBA
RPL38 has several distinctive structural features[@espinosa1997]:
- Small size: At only 71 amino acids, RPL38 is one of the smallest ribosomal proteins
- Lysine-rich region: Contains a distinctive lysine-rich sequence
- rRNA interaction sites: Multiple regions for 28S rRNA binding
- Surface localization: Positioned to interact with other ribosomal proteins
The small size and distinctive sequence of RPL38 may explain its specialized function in Hox mRNA translation.
Therapeutic approaches include[@diamondblackfan2020]:
- Corticosteroids: First-line treatment; mechanism involves translational enhancement
- L-leucine: Amino acid that improves translation efficiency
- Gene therapy: Autologous hematopoietic stem cell gene addition
- Supportive care: Transfusions for steroid-non-responsive patients
Current approaches focus on:
- Early intervention: Surgical correction of craniofacial abnormalities
- Developmental support: Physical and occupational therapy
- Future directions: Gene therapy approaches may become available
Understanding RPL38 has therapeutic implications:
- MDM2 inhibitors: May activate p53 in RPL38-deficient cells
- Ribosome-targeting drugs: Some chemotherapeutics work through ribosomal stress
- Synthetic lethality: RPL38-deficient cells may be selectively sensitive to certain agents
Insights from RPL38 biology inform:
- mTOR modulators: Can reduce ribosomal stress
- p53 modulators: Downstream targeting of stress response
- Translation enhancers: Supporting healthy protein synthesis
¶ Mermaid Diagram: RPL38 in Ribosomal Function and Development
flowchart TD
subgraph Normal_Ribosomal_Function
A["RPL38 Gene<br/>Transcription"] --> B["mRNA<br/>Translation"]
B --> C["RPL38 Protein<br/>Synthesis"]
C --> D["60S Subunit<br/>Assembly"]
D --> E["80S Ribosome<br/>Formation"]
E --> F["Protein<br/>Synthesis"]
F --> G["Cell<br/>Proliferation"]
end
subgraph Hox_Gene_Regulation
H["RPL38<br/>Specific mRNA"] --> I["Hox mRNA<br/>Translation"]
I --> J["Hox Protein<br/>Synthesis"]
J --> K["Segmental<br/>Patterning"]
K --> L["Tissue<br/>Development"]
end
subgraph Disease_Connections
M["RPL38<br/>Mutation"] --> N["Ribosomal<br/>Stress"]
N --> O["Impaired 60S<br/>Biogenesis"]
O --> P["Translational<br/>Defect"]
P --> Q["Selective<br/>Cytopenia"]
M --> R["Impaired Hox<br/>Translation"]
R --> S["Neural Crest<br/>Defects"]
S --> T["Craniofacial<br/>Anomalies"]
end
subgraph Neurodegeneration_Link
N --> U["Chronic<br/>Ribosomal Stress"]
U --> V["Neuronal p53<br/>Activation"]
V --> W["Neuronal<br/>Apoptosis"]
W --> X["Neurodegeneration"]
end
style M fill:#ffcdd2
style Q fill:#ffcdd2
style T fill:#ffcdd2
style X fill:#ef9a9a
- Gazda et al., Mutations in ribosomal proteins causing DBA (2024)
- Farheen et al., DBA: genetics, pathogenesis, and treatment (2020)
- Mills & Green, Ribosomopathies (2017)
- Warner & McIntosh, Extraribosomal functions of ribosomal proteins (2009)
- De Keersmaecker et al., How ribosomes translate cancer (2015)
- Kondrashov et al., Ribosome-mediated Hox mRNA translation (2011)
- Chenet et al., Ribosomal proteins in cancer (2022)
- Zhou et al., Ribosomal stress and neurodegeneration (2022)
- Khodorov et al., Protein synthesis in neurons (2002)
- Ding et al., Regulation of neuronal survival by ribosomal proteins (2005)
- Narla & Ebert, Ribosomopathies (2010)
- Trainor & Merrill, RPL38 in Hox gene regulation (2019)
- Espinosa et al., Primary sequence of human RPL38 (1997)
- Gopanenko et al., Knockdown of ribosomal protein eL38 (2021)
- Shi et al., RPL38 knockdown inhibits inflammation and apoptosis (2022)